Liver Biomarkers

2

Review clinical trials related to Liver Biomarkers. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Hepatoprotective Effects of Reishi Mushroom- (Ganoderma Lucidum) Among Metabolic Dysfunction-associated Fatty Liver Disease Patients

This 12-week RCT investigates the hepatoprotective and immunomodulatory effects of Ganoderma lucidum combined with a probiotic-rich diet in adults with MAFLD, assessing liver enzymes, lipid profile, inflammation, gut microbiota, and oxidative stress. Findings are expected to show dose-dependent improvements in hepatic fat, insulin resistance, and inflammatory markers, potentially reducing reliance on pharmacotherapy in

Participants needed: 102
Trial details
Age: 35-65Biological sex: AllType: InterventionalSponsor: University of LahoreUpdated: Apr 16, 2026Locations: 1
Eligibility criteria

Adults aged 35-65 years [+6]

● Diagnosed with severe cardiovascular disease, liver failure, or renal impairme... [+6]

Status: Not yet recruiting

Liver Affection in Pregnant Women at Sohag University Hospital

This study investigates the prevalence, causes, and clinical outcomes of liver disorders among pregnant women attending Sohag University Hospital. It aims to identify the most common hepatic conditions occurring during pregnancy, evaluate their impact on maternal and fetal health, and assess the effectiveness of current diagnostic and management approaches. By analyzing clinical data, laboratory findings, and pregnancy outcomes, the study highlights the importance of early detection and proper management of liver diseases to reduce associated complications and improve overall maternal-fetal prognosis.

Participants needed: 80
Trial details
Age: 18-50Biological sex: FemaleType: ObservationalSponsor: Eman Ashraf Saad AhmedUpdated: Dec 23, 2025
Eligibility criteria

Not listed